Page last updated: 2024-09-04

2-(1-octynyl)adenosine and n-formylmethionine leucyl-phenylalanine

2-(1-octynyl)adenosine has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(2-(1-octynyl)adenosine)
Trials
(2-(1-octynyl)adenosine)
Recent Studies (post-2010)
(2-(1-octynyl)adenosine)
Studies
(n-formylmethionine leucyl-phenylalanine)
Trials
(n-formylmethionine leucyl-phenylalanine)
Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine)
23036,71653356

Protein Interaction Comparison

ProteinTaxonomy2-(1-octynyl)adenosine (IC50)n-formylmethionine leucyl-phenylalanine (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, N; Katsuragi, T; Okajima, K1

Other Studies

1 other study(ies) available for 2-(1-octynyl)adenosine and n-formylmethionine leucyl-phenylalanine

ArticleYear
[Adenosine reduces ischemia/reperfusion-induced liver injury by inhibiting leukocyte activation].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114 Suppl 1

    Topics: Adenosine; Alkynes; Animals; Humans; In Vitro Techniques; Leukocyte Elastase; Liver; Male; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Rats; Rats, Wistar; Receptors, Purinergic P1; Reperfusion Injury; Transaminases; Triazines; Triazoles; Tumor Necrosis Factor-alpha

1999